Associated Labs/Orgs
Leuthardt Lab, Washington University St. Louis
Description
Neurotechnology company creating the first FDA-approved "Digital Pill," a brain-computer interface (BCI) with a focus to alleviate cognitive disorders, starting with depression. Device rebalances brain networks with individualized microstimulations.
Funding
$10M
Invasive / Non-invasive / Semi-invasive
Invasive
New/Existing Tech
Tech used (specifics)
Minimally-invasive “pill” implant for BCI
Techs Used
Neurostimulation
Year Founded
2019